Mesenchymal stem cell therapy - Meluha Therapeutics
Alternative Names: ChondroKiN™ - Meluha TherapeuticsLatest Information Update: 05 Jun 2024
At a glance
- Originator Meluha Therapeutics
- Class Mesenchymal stem cell therapies
- Mechanism of Action Cell replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase II Osteoarthritis